Furthermore, evidence suggests the presence of patatin-like phospholipase domain-containing protein 3 (PNPLA3), which is associated with an increased susceptibility to MASLD. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.